Last month, The Point of the Mountain released its latest Framework Plan.
Dan Lundergan, MHA, COO at University of Utah Health Hospitals and Clinics, has been appointed to the role of CEO. He has served as interim CEO since February and steps into the official role beginning immediately.
BlueWind Medical has announced that the 100th patient has been enrolled in its OASIS (Overactive bladder stimulation system) study—a clinical pivotal trial designed to test the safety and efficacy of the Renova iStim system in providing tibial neuromodulation (TNM) therapy.
Peer-reviewed results describe the Company’s test being used to confirm the presence of the virus on community waste, including mutated strains
On Monday, U.S. Rep. Burgess Owens (R-UT-4) spent the day visiting a number of life sciences companies – Owlet, Spectrum Solutions, Merit Medical, Matia Robotics and ARUP Laboratories.
Ron Heffernan, Managing Partner at Mountain Pacific Partners recently announced the launch of Mountain Pacific’s newest funds.
World-renowned neurologist and movement disorders specialist joins PhotoPharmics as company advances breakthrough device through pivotal clinical trial and to commercialization.
Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and Hologic.
Salt Lake City-based specialty medical device distributor is poised for value-creating diversification and supply chain innovation.
With more than two decades of healthcare expertise, Hastings brings track record of leading transformative growth.
ARUP Laboratories recently announced an investment in Techcyte Inc. as part of the Orem, Utah-based company’s new $21 million funding round.
Nominations are now open for BioUtah’s 2021 awards. The deadline for nominations is September 18.